NextCell Pharma AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2025	FY 2024	FY 2024	FY 2023
Period Ending	Jul '26 Jul 24, 2026	Dec '25 Dec 31, 2025	Aug '25 Aug 31, 2025	Dec '24 Dec 31, 2024	Aug '24 Aug 31, 2024	Aug '23 Aug 31, 2023
Market Cap	128	81	130	208	93	124
Market Cap Growth	5.92%	-37.52%	-37.21%	123.62%	-25.00%	-43.31%
Enterprise Value	95.33	55.39	91.61	174.88	46.04	73.74
Last Close Price	1.01	0.73	1.17	2.84	1.27	3.60
PS Ratio	13.81	5.83	11.78	18.41	8.23	8.87
PB Ratio	2.32	1.61	1.96	3.71	1.37	1.63
P/TBV Ratio	1.95	1.23	1.35	2.07	0.77	1.63
EV/Sales Ratio	10.31	3.97	8.28	15.51	4.08	5.28
Net Debt / Equity Ratio	-0.59	-0.51	-0.58	-0.58	-0.69	-0.66
Net Debt / EBITDA Ratio	0.85	0.54	1.16	0.77	1.11	1.23
Net Debt / FCF Ratio	0.77	0.47	0.99	0.83	1.24	1.04
Asset Turnover	0.16	0.21	0.16	0.15	0.13	0.13
Inventory Turnover	23.59	26.97	17.23	22.79	22.79	14.12
Quick Ratio	4.86	3.92	8.05	6.62	5.06	5.32
Current Ratio	4.90	5.16	10.02	8.27	6.15	6.67
Return on Equity (ROE)	-75.06%	-95.55%	-57.42%	-63.70%	-58.55%	-41.63%
Return on Assets (ROA)	-60.03%	-79.77%	-50.28%	-55.76%	-50.76%	-38.41%
Return on Invested Capital (ROIC)	-139.32%	-179.94%	-118.98%	-152.92%	-161.86%	-166.24%
Return on Capital Employed (ROCE)	-69.22%	-89.10%	-54.48%	-62.04%	-57.50%	-41.74%
Buyback Yield / Dilution	-110.06%	-11.67%	-87.38%	0.09%	-18.72%	0.00%
Total Shareholder Return	-110.06%	-11.67%	-87.38%	0.09%	-18.72%	0.00%